SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003918
Filing Date
2015-05-11
Accepted
2015-05-11 16:23:30
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mstx-10q_20150331.htm 10-Q 778931
2 EX-10.1 mstx-ex101_20150331181.htm EX-10.1 24103
3 EX-31.1 mstx-ex311_20150331175.htm EX-31.1 13528
4 EX-31.2 mstx-ex312_20150331176.htm EX-31.2 13569
5 EX-32.1 mstx-ex321_20150331177.htm EX-32.1 9416
  Complete submission text file 0001564590-15-003918.txt   4503182

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mstx-20150331.xml EX-101.INS 637389
7 XBRL TAXONOMY EXTENSION SCHEMA mstx-20150331.xsd EX-101.SCH 36507
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20150331_cal.xml EX-101.CAL 34499
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20150331_def.xml EX-101.DEF 70685
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20150331_lab.xml EX-101.LAB 234313
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20150331_pre.xml EX-101.PRE 177219
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 15851050
SIC: 2834 Pharmaceutical Preparations